Stockreport

Repligen Conference: CEO touts differentiated bioprocessing portfolio; CFO targets 30% EBITDA margin [Yahoo! Finance]

Repligen Corporation  (RGEN) 
Last repligen corporation earnings: 2/20 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: repligen.com/investors
PDF Repligen (NASDAQ:RGEN) executives outlined a strategy focused on portfolio breadth, innovation, and commercial execution during a recent discussion with Life Science An [Read more]